These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 6683088)
41. Subacute toxic delirium caused by nitrous oxide may be an acute withdrawal state. Gillman MA; Lichtigfeld FJ; Sandyk R Arch Neurol; 1984 Jul; 41(7):704. PubMed ID: 6743054 [No Abstract] [Full Text] [Related]
42. Morphine tolerance and physical dependence: influence of cholinergic agonists and antagonists. Bhargava HN; Way EL Eur J Pharmacol; 1976 Mar; 36(1):79-88. PubMed ID: 944135 [TBL] [Abstract][Full Text] [Related]
43. Evidence for the involvement of opioidergic systems in medprotine-induced analgesia in the mouse. Caruso A; Cutuli VM; Candido P; De Bernardis E; Amico-Roxas M Drugs Exp Clin Res; 1994; 20(1):19-27. PubMed ID: 7924891 [TBL] [Abstract][Full Text] [Related]
44. Postoperative opisthotonus and torticollis after fentanyl, enflurane, and nitrous oxide. Dehring DJ; Gupta B; Peruzzi WT Can J Anaesth; 1991 Oct; 38(7):919-25. PubMed ID: 1742831 [TBL] [Abstract][Full Text] [Related]
48. The influence of electro-acupuncture on naloxone-induced morphine withdrawal in mice: elevation of brain opiate-like activity. Ho WK; Wen HL; Lam S; Ma L Eur J Pharmacol; 1978 May; 49(2):197-9. PubMed ID: 566205 [No Abstract] [Full Text] [Related]
49. Effects of cholinergic and anticholinergic drugs and a partial cholinergic agonist on the development and expression of physical dependence on morphine in rat. Frederickson RC; Pinsky C J Pharmacol Exp Ther; 1975 Apr; 193(1):44-55. PubMed ID: 1169318 [TBL] [Abstract][Full Text] [Related]
50. Anticonvulsive effects of kappa-opioid receptor modulation in an animal model of ethanol withdrawal. Beadles-Bohling AS; Wiren KM Genes Brain Behav; 2006 Aug; 5(6):483-96. PubMed ID: 16923153 [TBL] [Abstract][Full Text] [Related]
51. Further comments on the effects of nitrous oxide treatment on alcohol withdrawal. Gillman MA; Lichtigfeld FJ J Clin Psychopharmacol; 2004 Aug; 24(4):473-5. PubMed ID: 15232353 [No Abstract] [Full Text] [Related]
52. Opioid mechanisms of some behavioral effects of ketamine. Fidecka S Pol J Pharmacol Pharm; 1987; 39(4):353-60. PubMed ID: 3449808 [TBL] [Abstract][Full Text] [Related]
53. Spinal NMDA receptor--nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat. Buccafusco JJ; Terry AV; Shuster L Brain Res; 1995 May; 679(2):189-99. PubMed ID: 7633880 [TBL] [Abstract][Full Text] [Related]
54. Evidence that chronic hyperprolactinemia effects skin temperature regulation through an opioid mechanism. Simpkins JW; Taylor ST; Gabriel SM; Katovich MJ; Millard WJ Neuroendocrinology; 1984 Oct; 39(4):321-9. PubMed ID: 6092986 [TBL] [Abstract][Full Text] [Related]
55. Endorphins and pain. Davis GC Psychiatr Clin North Am; 1983 Sep; 6(3):473-87. PubMed ID: 6316302 [TBL] [Abstract][Full Text] [Related]
57. [Nitrous oxide in anesthesia--present status of the use of nitrous oxide, risks for patients and personnel and treatment of side effects]. Rupreht J; Erdmann W; Dzoljic M; van Stolk MA Anaesthesiol Reanim; 1989; 14(5):251-9. PubMed ID: 2684201 [TBL] [Abstract][Full Text] [Related]
58. The short- and long-termed effects of beta-endorphin on the opiate abstinence syndrome in rats. Haracz JL; Tseng LF Commun Psychopharmacol; 1980; 4(3):219-24. PubMed ID: 6262008 [No Abstract] [Full Text] [Related]
59. Opiate peptides, analgesia, and the neuroendocrine system. Br Med J; 1980 Mar; 280(6216):741-2. PubMed ID: 6966173 [No Abstract] [Full Text] [Related]
60. The uses of analgesic nitrous oxide in neuropsychiatry. Gillman MA; Lichtigfeld FJ S Afr Med J; 1994 Oct; 84(10):706. PubMed ID: 7839271 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]